000154040 001__ 154040
000154040 005__ 20230426103840.0
000154040 0247_ $$2doi$$a10.1080/13803395.2020.1825634
000154040 0247_ $$2ISSN$$a0168-8634
000154040 0247_ $$2ISSN$$a1380-3395
000154040 0247_ $$2ISSN$$a1744-411X
000154040 0247_ $$2altmetric$$aaltmetric:92531916
000154040 0247_ $$2pmid$$apmid:33043797
000154040 037__ $$aDZNE-2021-00022
000154040 041__ $$aEnglish
000154040 082__ $$a610
000154040 1001_ $$0P:(DE-2719)2811919$$aSulzer, Patricia$$b0$$eFirst author
000154040 245__ $$aA time-efficient screening tool for activities of daily living functions in Parkinson’s disease dementia
000154040 260__ $$aAbingdon$$bRoutledge, Taylor & Francis Group86092$$c2020
000154040 3367_ $$2DRIVER$$aarticle
000154040 3367_ $$2DataCite$$aOutput Types/Journal article
000154040 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1618914640_3881
000154040 3367_ $$2BibTeX$$aARTICLE
000154040 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154040 3367_ $$00$$2EndNote$$aJournal Article
000154040 520__ $$aInstructionIn Parkinson’s disease (PD), activities of daily living (ADL) impairments are crucial for diagnosis of dementia (PDD). Performance-based tests are promising tools to discriminate between different levels of cognitive impairment in PD; however, the value of those tests for diagnosis of PDD is only sparsely investigated. Therefore, we evaluated the Erlangen Test of Activities of Daily Living (E-ADL), a time-efficient performance-based ADL test, in PD.MethodIn this cross-sectional study, 40 PD patients with normal cognition (PD-NC), 45 patients with mild cognitive impairment (PD-MCI) and 21 patients with PDD were assessed with a comprehensive ADL and cognitive test battery.ResultsInterrater reliability (rs =.86) indicated high consistency of the standardized E-ADL scoring system between raters. The E-ADL correlated significantly with other tests of ADL functions (p <.01), highest with an alternative performance-based ADL test (rs = −.52), and lowest with self-ratings and a physician-rated scale. The E-ADL was also associated with cognitive impairment (p <.01), but also with motor impairment. A binary logistic regression model verified that the E-ADL (p =.04) was an independent predictor of PDD, in addition to motor impairment explaining 53.3% of variance. Receiver operating characteristic curve analysis of the E-ADL revealed an area under the curve of 0.78, a specificity of 77%, and a sensitivity of 67% for diagnosis PDD.ConclusionsThe standardized, easy, and quick to administer E-ADL showed acceptable levels of reliability, and validity in PD and measures cognitive-driven ADL functions. Therefore, it might be a suitable test to support diagnosis of PDD in the clinical daily routine.
000154040 536__ $$0G:(DE-HGF)POF3-345$$a345 - Population Studies and Genetics (POF3-345)$$cPOF3-345$$fPOF III$$x0
000154040 588__ $$aDataset connected to CrossRef
000154040 650_2 $$2MeSH$$aActivities of Daily Living: psychology
000154040 650_2 $$2MeSH$$aAged
000154040 650_2 $$2MeSH$$aAged, 80 and over
000154040 650_2 $$2MeSH$$aCognitive Dysfunction: diagnosis
000154040 650_2 $$2MeSH$$aCognitive Dysfunction: etiology
000154040 650_2 $$2MeSH$$aCognitive Dysfunction: psychology
000154040 650_2 $$2MeSH$$aCross-Sectional Studies
000154040 650_2 $$2MeSH$$aDementia: diagnosis
000154040 650_2 $$2MeSH$$aDementia: etiology
000154040 650_2 $$2MeSH$$aDementia: psychology
000154040 650_2 $$2MeSH$$aFemale
000154040 650_2 $$2MeSH$$aHumans
000154040 650_2 $$2MeSH$$aMale
000154040 650_2 $$2MeSH$$aMiddle Aged
000154040 650_2 $$2MeSH$$aMotor Skills
000154040 650_2 $$2MeSH$$aNeuropsychological Tests
000154040 650_2 $$2MeSH$$aParkinson Disease: complications
000154040 650_2 $$2MeSH$$aParkinson Disease: diagnosis
000154040 650_2 $$2MeSH$$aParkinson Disease: psychology
000154040 650_2 $$2MeSH$$aROC Curve
000154040 650_2 $$2MeSH$$aSelf Concept
000154040 650_2 $$2MeSH$$aSensitivity and Specificity
000154040 7001_ $$0P:(DE-2719)9001471$$aLiebig, Luise$$b1$$udzne
000154040 7001_ $$aCsoti, Ilona$$b2
000154040 7001_ $$aGraessel, Elmar$$b3
000154040 7001_ $$0P:(DE-2719)2812736$$aWurster, Isabel$$b4
000154040 7001_ $$0P:(DE-HGF)0$$aBerg, Daniela$$b5
000154040 7001_ $$0P:(DE-2719)2109499$$aLiepelt-Scarfone, Inga$$b6$$eLast author
000154040 773__ $$0PERI:(DE-600)605982-X$$a10.1080/13803395.2020.1825634$$gVol. 42, no. 8, p. 867 - 879$$n8$$p867 - 879$$tJournal of clinical and experimental neuropsychology$$v42$$x1744-411X$$y2020
000154040 909CO $$ooai:pub.dzne.de:154040$$pVDB
000154040 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811919$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000154040 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001471$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000154040 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812736$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000154040 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2109499$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000154040 9131_ $$0G:(DE-HGF)POF3-345$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vPopulation Studies and Genetics$$x0
000154040 9132_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000154040 9141_ $$y2020
000154040 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154040 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154040 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN EXP NEUROPSYC : 2015
000154040 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000154040 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000154040 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000154040 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000154040 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154040 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154040 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aDBCoverage$$bSocial Sciences Citation Index
000154040 915__ $$0StatID:(DE-HGF)1180$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences
000154040 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000154040 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000154040 9201_ $$0I:(DE-2719)1210000$$kAG Gasser 1$$lParkinson Genetics$$x0
000154040 9201_ $$0I:(DE-2719)1240004$$kBiobanking Facility Tübingen$$lBiobanking Facility Tübingen$$x1
000154040 980__ $$ajournal
000154040 980__ $$aVDB
000154040 980__ $$aI:(DE-2719)1210000
000154040 980__ $$aI:(DE-2719)1240004
000154040 980__ $$aUNRESTRICTED